Drugs
-
Estradiol Transdermal Spray (marketed as Evamist) Information
Evamist (estradiol transdermal spray) is an estrogen indicated for the treatment of moderate to severe vasomotor symptoms due to menopause.
To report any serious adverse events associated with the use of this drug, please contact the FDA MedWatch program using the contact information at the bottom of this page.
-
Related Information
- FDA Drug Info Rounds: Evamist
Training video for practicing pharmacists (9/30/2010) FDA Drug Safety Communication: Ongoing safety review of Evamist (estradiol transdermal spray) and unintended exposure of children and pets to topical estrogen
7/29/2010FDA Drug Safety Podcast for Healthcare Professionals: Ongoing safety review of Evamist (estradiol transdermal spray) and unintended exposure of children and pets to topical estrogen FDA Drug Safety Podcast: Avoid Unintentional Exposure of Children and Pets to Evamist Keep Kids, Pets Away From Skin Sprayed With Evamist
7/29/2010
-
-
Labeling and Regulatory History from Drugs@FDA
-
Contact FDA
1-800-332-1088
1-800-FDA-0178 Fax
Report a Serious Problem
Regular Mail: Use postage-paid FDA Form 3500
Mail to: MedWatch 5600 Fishers Lane
Rockville, MD 20857
-
-